This inventor holds 1 USPTO granted patent. Top assignees: Aalborg University, Region Nordjylland, Aalborg Sygehus. Active years: 2016.
Company Filing History:
1 out of 43 
1 out of 2 Years Active: 2016
Title: Michael Svorkmo: Innovator in Blood Flow Measurement Technology
Introduction
Michael Svorkmo is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of medical technology, particularly in the measurement of blood flow properties. His innovative approach has the potential to enhance clinical evaluations and surgical outcomes.
Latest Patents
Svorkmo holds a patent for a "System for determining flow properties of a blood vessel." This invention relates to a method for providing quantitative measures of the flow property of a blood vessel. The method is based on analyzing cross-sectional images of a vessel by estimating the area of the lumen of the vessel. It involves determining a point within the walls of the vessel, approximating the inner circumference of the wall, and measuring the area of the closed path when the vessel is most expanded. This method may enable clinical personnel to quickly evaluate the flow property of an inserted bypass vessel, thereby concluding if the surgical intervention is successful or if adjustments are required. Svorkmo's patent is a testament to his innovative spirit and dedication to improving medical practices.
Career Highlights
Throughout his career, Michael Svorkmo has worked with several reputable organizations, including Aalborg University and Aalborg Sygehus. His experience in these institutions has allowed him to develop and refine his inventions, contributing to advancements in medical technology.
Collaborations
Some of his notable coworkers include Niels-Henrik Staalsen and Kasper Lundhus. Their collaboration has likely played a role in the development and success of Svorkmo's innovative projects.
Conclusion
Michael Svorkmo's contributions to the field of blood flow measurement technology highlight his role as an influential inventor. His patented method has the potential to significantly impact clinical practices and improve patient outcomes.